Which statement best describes side effects of oral carbonic anhydrase inhibitors?

Which statement best describes side effects of oral carbonic anhydrase inhibitors?

• A. Many systemic side effects
• B. Mild systemic effects
• C. No systemic effects
• D. Only electrolyte changes

Answer: (B)

The main idea here is the side effect profile of oral carbonic anhydrase inhibitors. These drugs, such as acetazolamide, work systemically to lower intraocular pressure by inhibiting carbonic anhydrase in the ciliary body, which reduces aqueous humor formation. Because their action is systemic, they can cause adverse effects beyond the eye, but in typical use these effects are usually mild. Common systemic effects include symptoms like tingling or numbness in the extremities, fatigue, and mild gastrointestinal discomfort. They reflect the drug’s influence on bicarbonate handling and acid–base balance throughout the body. More serious issues—such as metabolic acidosis, electrolyte disturbances (like hypokalemia), dehydration, or kidney stone formation due to alkaline urine—can occur, especially with longer use or higher doses, but they are less common. So, while there are systemic effects, they are generally mild in most patients, making that description the best fit. This differs from options suggesting no systemic effects (which is incorrect) or implying only electrolyte changes (which omits non-electrolyte symptoms like paresthesias and fatigue) or overstating the frequency of systemic side effects as “many.”

The main idea here is the side effect profile of oral carbonic anhydrase inhibitors. These drugs, such as acetazolamide, work systemically to lower intraocular pressure by inhibiting carbonic anhydrase in the ciliary body, which reduces aqueous humor formation. Because their action is systemic, they can cause adverse effects beyond the eye, but in typical use these effects are usually mild.

Common systemic effects include symptoms like tingling or numbness in the extremities, fatigue, and mild gastrointestinal discomfort. They reflect the drug’s influence on bicarbonate handling and acid–base balance throughout the body. More serious issues—such as metabolic acidosis, electrolyte disturbances (like hypokalemia), dehydration, or kidney stone formation due to alkaline urine—can occur, especially with longer use or higher doses, but they are less common. So, while there are systemic effects, they are generally mild in most patients, making that description the best fit.

This differs from options suggesting no systemic effects (which is incorrect) or implying only electrolyte changes (which omits non-electrolyte symptoms like paresthesias and fatigue) or overstating the frequency of systemic side effects as “many.”